Key result
Femoral autologous blood reinfusion appears safe in iatrogenic hemorrhagic cardiac tamponade with 0 major adverse reactions.
Why the study?
Iatrogenic hemorrhagic pericardial tamponade is a life-threatening condition requiring emergency pericardiocentesis, and the safety and feasibility of autologous blood reinfusion in this context needed evaluation.
Is autologous blood reinfusion through a femoral vein safe and feasible in patients with iatrogenic acute hemorrhagic cardiac tamponade?
Cohort (n=30)
No
Is autologous blood reinfusion through a femoral vein safe and feasible in patients with iatrogenic acute hemorrhagic cardiac tamponade?
Autologous blood reinfusion of pericardial blood through a femoral vein is a safe and effective strategy to stabilize patients with iatrogenic hemorrhagic cardiac tamponade during catheter-based procedures.
Answers are grounded in this paper and cite their sources.
May aid stabilization in procedural tamponade; hypothesis-generating and requires prospective validation.
BACKGROUND: Iatrogenic hemorrhagic pericardial tamponade (IHPT) represents a life-threating condition requiring emergency pericardiocentesis. In this clinical context, reinfusion of pericardial blood can stabilize the patient and sustain hemodynamic conditions. AIMS AND METHODS: We reviewed all cases of IHPT occurred at our hospital over a 10 years span. In all patient autologous blood reinfusion through a femoral vein was performed. RESULTS: In our clinical experience of 30 consecutive patients with hemorrhagic cardiac tamponade, this technique was successful to limit blood transfusions, to prevent further clinical worsening and bridge patients with intractable bleeding, to cardiac surgery. No major adverse reactions were directly related to blood autotransfusion. CONCLUSION: In the complex clinical scenario of acute tamponade occurring during catheter-based cardiac procedures, autotransfusion of pericardial blood through a femoral vein is safe and effective. It can be a useful trick up the sleeve of the interventional cardiologist.
No takes yet. Share an insight, caveat, or question.
Fiocca et al. (2018) conducted a cohort in Iatrogenic hemorrhagic pericardial tamponade (n=30). Autologous blood reinfusion through a femoral vein was evaluated on Safety and feasibility (major adverse reactions).
Synapse has enriched 10 related papers. Consider them for comparative context: